生物安全概念股普漲 智飛生物、沃森生物、康泰生物均創歷史新高
格隆匯4月27日丨生物安全概念股現普漲行情,其中,智飛生物漲近8%創歷史新高,年內累漲67%;沃森生物漲超6%創歷史新高,年內累漲27%;華大基因漲超4%,年內累漲60%;康泰生物漲近4%創歷史新高,年內累漲56%。貝瑞基因、生物股份、瑞普生物、天康生物等均有明顯上漲。
生物安全法草案二審稿4月26日提請十三屆全國人大常委會第十七次會議審議。草案明確,生物安全是國家安全的重要組成部分,維護國家生物安全應當貫徹總體國家安全觀。在防控重大新發突發傳染病、動植物疫情方面,草案增加了監測預警制度,要求專業機構開展主動監測,收集、分析、報告監測信息,預測新發突發傳染病、動植物疫病的發生、流行趨勢;國務院有關部門和縣級以上地方人民政府及時發佈預警,採取相應的預防、控制措施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.